Compare the Renal Protective Effects of Febuxostat and Benzbromarone in Chronic Kidney Disease Patients With GFR 20-50ml/Min
Phase of Trial: Phase III
Latest Information Update: 09 May 2016
At a glance
- Drugs Benzbromarone (Primary) ; Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 05 May 2016 Planned End Date changed from 1 Feb 2016 to 1 Dec 2018.
- 05 May 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2018.
- 21 Jan 2015 New trial record